Evidence map›Paper›PMID 11133020›Full record

ArticleGlycoconjugate journal1999

Lectin analysis of human immunoglobulin G N-glycan sialylation.

M Dalziel, I McFarlane, J S Axford

Abstract read
PubMed Publisher
In one paragraph

Article in Glycoconjugate journal, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Human plasma protein N-glycosylation.Glycoconjugate journal · 2016
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Glycoproteins of drusen and drusen-like lesions.Journal of molecular histology · 2008
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

M DalzielICRF Breast Cancer Biology Group, Thomas Guy House, Guy's Hospital, London, UK. M.Dalziel@icrf.icnet.uk
I McFarlane
J S Axford
Guy's Hospital · GBSt George's Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The lectins Sambucus nigra agglutinin (SNA) and Ricinus communis agglutinin (RCA), specific for alpha2,6 linked sialylation, and terminal galactose respectively were used to study the occurrence, linkage and distribution of human immunoglobulin G (IgG) sialylation. SNA was shown to bind N-glycan alpha2,6-linked sialic acid only. Sialidase analysis confirmed that this is the dominant, if not exclusive linkage. Total IgG sialylation was estimated at 1.0 microg SA/mg IgG (or about 0.5 mole per mole) using a biochemical sialic acid assay. SNA displayed strong binding to the IgG Fab fragment in both its native and denatured state. In contrast, SNA failed to bind the IgG Fc fragment in its native form, but displayed strong binding after the Fc was denatured. This allowed the construction of quantitative assays capable of measuring both IgG Fab and Fc alpha2,6-sialylation without the need for enzymatic peptide digestion.

Indexed as

Plant LectinsAmidohydrolasesBinding SitesCarbohydrate ConformationHumansImmunoglobulin Fab FragmentsImmunoglobulin Fc FragmentsImmunoglobulin GIn Vitro TechniquesLectinsNeuraminidasePeptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine AmidasePolysaccharidesRibosome Inactivating ProteinsSialic AcidsAmidohydrolasesImmunoglobulin Fab FragmentsImmunoglobulin Fc FragmentsImmunoglobulin GLectinsNeuraminidasePeptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine AmidasePlant LectinsPolysaccharidesRibosome Inactivating ProteinsRicinus communis agglutinin-1Sambucus nigra lectinsSialic Acids

Identifiers

PMID11133020
OpenAlexW1497599437

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.